Rubio DM, Schoenbaum EE, Lee LS, Schteingart DE, Marantz PR, Anderson KE, et al. Defining translational research: implications for training. Acad Med. 2010;85(3):470–5.
Article
PubMed Central
PubMed
Google Scholar
Keramaris NC, Kanakaris NK, Tzioupis C, Kontakis G, Giannoudis PV. Translational research: from benchside to bedside. Injury. 2008;39(6):643–50.
Article
CAS
PubMed
Google Scholar
Littman BH, Di Mario L, Plebani M, Marincola FM. What’s next in translational medicine? Clin Sci (Lond). 2007;112(4):217–27.
Article
Google Scholar
Marincola FM. Translational Medicine: A two-way road. J Transl Med. 2003;1(1):1.
Article
PubMed Central
PubMed
Google Scholar
Davis D, Evans M, Jadad A, Perrier L, Rath D, Ryan D, et al. The case for knowledge translation: shortening the journey from evidence to effect. BMJ. 2003;327(7405):33–5.
Article
PubMed Central
PubMed
Google Scholar
Woolf SH. The meaning of translational research and why it matters. JAMA. 2008;299(2):211–3.
Article
CAS
PubMed
Google Scholar
National Institutes of Health. Definitions under Subsection 1 (Research Objectives), Section I (Funding Opportunity Description), Part II (Full Text of Announcement), of RFA-RM-07-007: Institutional Clinical and Translational Science Award (U54). http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-07-007.html. Accessed January 4 2015.
Waldman SA, Terzic A. Clinical and translational science: from bench-bedside to global village. Clin Transl Sci. 2010;3(5):254–7.
Article
PubMed
Google Scholar
Kon AA. The Clinical and Translational Science Award (CTSA) Consortium and the translational research model. Am J Bioeth. 2008;8(3):58–60. discussion W1-3.
Article
PubMed Central
PubMed
Google Scholar
Butler D. Translational research: crossing the valley of death. Nature. 2008;453(7197):840–2.
Article
CAS
PubMed
Google Scholar
Westfall JM, Mold J, Fagnan L. Practice-based research--“Blue Highways” on the NIH roadmap. JAMA. 2007;297(4):403–6.
Article
CAS
PubMed
Google Scholar
Brook RH. Medical leadership in an increasingly complex world. JAMA. 2010;304(4):465–6.
Article
CAS
PubMed
Google Scholar
Sung NS, Crowley Jr WF, Genel M, Salber P, Sandy L, Sherwood LM, et al. Central challenges facing the national clinical research enterprise. JAMA. 2003;289(10):1278–87.
Article
PubMed
Google Scholar
Canadian Institute of Health Research: Canada's Strategy for Patient-Oriented Research. Improving health Outcomes through evidence-informed care. 2011. www.cihr-irsc.gc.ca/e/44000.html. Accessed January 5 2015.
Reis SE, McDonald MC, Byers SJ. Crossing the research valleys of death: the University of Pittsburgh approach. Clin Transl Sci. 2008;1(1):9–10.
Article
PubMed Central
PubMed
Google Scholar
United States Renal Data Service. USRDS 2013 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes, Digestive, and Kidney Diseases; 2013.
Google Scholar
Matas AJ, Smith JM, Skeans MA, Thompson B, Gustafson SK, Schnitzler MA, et al. OPTN/SRTR 2012 Annual Data Report: kidney. Am J Transplant. 2014;14 Suppl 1:11–44.
Article
PubMed
Google Scholar
Halawa A. The early diagnosis of acute renal graft dysfunction: a challenge we face. The role of novel biomarkers. Ann Transplant. 2011;16(1):90–8.
PubMed
Google Scholar
Kim SC, Page EK, Knechtle SJ. Urine proteomics in kidney transplantation. Transplant Rev (Orlando). 2014;28(1):15–20.
Article
CAS
Google Scholar
Bhangoo RS, Hall IE, Reese PP, Parikh CR. Deceased-donor kidney perfusate and urine biomarkers for kidney allograft outcomes: a systematic review. Nephrol Dial Transplant. 2012;27(8):3305–14.
Article
PubMed Central
CAS
PubMed
Google Scholar
Lesko LJ, Atkinson Jr AJ. Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: criteria, validation, strategies. Annu Rev Pharmacol Toxicol. 2001;41:347–66.
Article
CAS
PubMed
Google Scholar
Ting YT, Coates PT, Walker RJ, McLellan AD. Urinary tubular biomarkers as potential early predictors of renal allograft rejection. Nephrology (Carlton). 2012;17(1):11–6.
Article
CAS
Google Scholar
Mishra J, Ma Q, Kelly C, Mitsnefes M, Mori K, Barasch J, et al. Kidney NGAL is a novel early marker of acute injury following transplantation. Pediatr Nephrol. 2006;21(6):856–63.
Article
PubMed
Google Scholar
Lebkowska U, Malyszko J, Lebkowska A, Koc-Zorawska E, Lebkowski W, Malyszko JS, et al. Neutrophil gelatinase-associated lipocalin and cystatin C could predict renal outcome in patients undergoing kidney allograft transplantation: a prospective study. Transplant Proc. 2009;41(1):154–7.
Article
CAS
PubMed
Google Scholar
Schaub S, Mayr M, Honger G, Bestland J, Steiger J, Regeniter A, et al. Detection of subclinical tubular injury after renal transplantation: comparison of urine protein analysis with allograft histopathology. Transplantation. 2007;84(1):104–12.
Article
CAS
PubMed
Google Scholar
Heyne N, Kemmner S, Schneider C, Nadalin S, Konigsrainer A, Haring HU. Urinary neutrophil gelatinase-associated lipocalin accurately detects acute allograft rejection among other causes of acute kidney injury in renal allograft recipients. Transplantation. 2012;93(12):1252–7.
Article
PubMed
Google Scholar
Blydt-Hansen TD, Sharma A, Gibson IW, Mandal R, Wishart DS. Urinary metabolomics for noninvasive detection of borderline and acute T cell-mediated rejection in children after kidney transplantation. Am J Transplant. 2014;14(10):2339–49.
Article
CAS
PubMed
Google Scholar
Puttarajappa C, Shapiro R, Tan HP. Antibody-mediated rejection in kidney transplantation: a review. J Transplant. 2012;2012:193724.
Article
PubMed Central
PubMed
Google Scholar
Mauiyyedi S, Colvin RB. Humoral rejection in kidney transplantation: new concepts in diagnosis and treatment. Curr Opin Nephrol Hypertens. 2002;11(6):609–18.
Article
PubMed
Google Scholar
Sureshkumar KK, Hussain SM, Carpenter BJ, Sandroni SE, Marcus RJ. Antibody-mediated rejection following renal transplantation. Expert Opin Pharmacother. 2007;8(7):913–21.
Article
CAS
PubMed
Google Scholar
Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant. 2009;9(3):S1–155.
Google Scholar
Roberts DM, Jiang SH, Chadban SJ. The treatment of acute antibody-mediated rejection in kidney transplant recipients-a systematic review. Transplantation. 2012;94(8):775–83.
Article
CAS
PubMed
Google Scholar
Klein J. George Snell's first foray into the unexplored territory of the major histocompatibility complex. Genetics. 2001;159(2):435–9.
PubMed Central
CAS
PubMed
Google Scholar
Benacerraf B. Significance and biological function of class II MHC molecules. Rous-Whipple Award lecture 1985. Am J Pathol. 1985;120(3):334–43.
PubMed Central
CAS
PubMed
Google Scholar
Cecka JM. Current methodologies for detecting sensitization to HLA antigens. Curr Opin Organ Transplant. 2011;16(4):398–403.
Article
CAS
PubMed
Google Scholar
Tinckam K. Histocompatibility methods. Transplant Rev (Orlando). 2009;23(2):80–93.
Article
Google Scholar
Mulley WR, Kanellis J. Understanding crossmatch testing in organ transplantation: A case-based guide for the general nephrologist. Nephrology (Carlton). 2011;16(2):125–33.
Article
Google Scholar
Huber L, Lachmann N, Durr M, Matz M, Liefeldt L, Neumayer HH, et al. Identification and therapeutic management of highly sensitized patients undergoing renal transplantation. Drugs. 2012;72(10):1335–54.
Article
CAS
PubMed
Google Scholar
International Histocompatibility Working Group: A brief history of the international histocompatibility workshops. http://www.ihwg.org/about/history.html.
Zachary AA, Montgomery RA, Leffell MS. Defining unacceptable HLA antigens. Curr Opin Organ Transplant. 2008;13(4):405–10.
Article
PubMed
Google Scholar
Jackson AM, Leffell MS, Montgomery RA, Zachary AA. A GPS for finding the route to transplantation for the sensitized patient. Curr Opin Organ Transplant. 2012;17(4):433–9.
Article
PubMed
Google Scholar
Montgomery RA. Renal transplantation across HLA and ABO antibody barriers: integrating paired donation into desensitization protocols. Am J Transplant. 2010;10(3):449–57.
Article
CAS
PubMed
Google Scholar
Fuggle SV, Martin S. Tools for human leukocyte antigen antibody detection and their application to transplanting sensitized patients. Transplantation. 2008;86(3):384–90.
Article
CAS
PubMed
Google Scholar
Claas FH, Witvliet MD, Duquesnoy RJ, Persijn GG, Doxiadis II. The acceptable mismatch program as a fast tool for highly sensitized patients awaiting a cadaveric kidney transplantation: short waiting time and excellent graft outcome. Transplantation. 2004;78(2):190–3.
Article
PubMed
Google Scholar
Murphey CL, Bingaman AW. Histocompatibility considerations for kidney paired donor exchange programs. Curr Opin Organ Transplant. 2012;17(4):427–32.
Article
CAS
PubMed
Google Scholar
Segev DL, Gentry SE, Warren DS, Reeb B, Montgomery RA. Kidney paired donation and optimizing the use of live donor organs. JAMA. 2005;293(15):1883–90.
Article
CAS
PubMed
Google Scholar
Chkhotua A. Paired kidney donation: outcomes, limitations, and future perspectives. Transplant Proc. 2012;44(6):1790–2.
Article
CAS
PubMed
Google Scholar
Glotz D, Haymann JP, Sansonetti N, Francois A, Menoyo-Calonge V, Bariety J, et al. Suppression of HLA-specific alloantibodies by high-dose intravenous immunoglobulins (IVIg). A potential tool for transplantation of immunized patients. Transplantation. 1993;56(2):335–7.
Article
CAS
PubMed
Google Scholar
Tyan DB, Li VA, Czer L, Trento A, Jordan SC. Intravenous immunoglobulin suppression of HLA alloantibody in highly sensitized transplant candidates and transplantation with a histoincompatible organ. Transplantation. 1994;57(4):553–62.
Article
CAS
PubMed
Google Scholar
Montgomery RA, Zachary AA, Racusen LC, Leffell MS, King KE, Burdick J, et al. Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients. Transplantation. 2000;70(6):887–95.
Article
CAS
PubMed
Google Scholar
Schweitzer EJ, Wilson JS, Fernandez-Vina M, Fox M, Gutierrez M, Wiland A, et al. A high panel-reactive antibody rescue protocol for cross-match-positive live donor kidney transplants. Transplantation. 2000;70(10):1531–6.
Article
CAS
PubMed
Google Scholar
Iyer HS, Jackson AM, Zachary AA, Montgomery RA. Transplanting the highly sensitized patient: trials and tribulations. Curr Opin Nephrol Hypertens. 2013;22(6):681–8.
Article
PubMed
Google Scholar
Canadian Transplant Registries. Organ and Tissue Donation and Transplantation. http://www.organsandtissues.ca/s/english-expert/nowhsp-registries. Accessed July 5 2015.
Canadian Blood Services. New program will improve chances of a kidney transplant for hard-to-match patients. https://www.blood.ca/en/media/new-program-will-improve-chances-kidney-transplant-hard-match-patients. Accessed July 5 2015.
Montgomery RA, Lonze BE, King KE, Kraus ES, Kucirka LM, Locke JE, et al. Desensitization in HLA-incompatible kidney recipients and survival. N Engl J Med. 2011;365(4):318–26.
Article
CAS
PubMed
Google Scholar
Cole E, Tinckam KJ. Desensitization outcomes: quantifying and questioning. Am J Transplant. 2014;14(7):1475–6.
Article
CAS
PubMed
Google Scholar
Solez K, Axelsen RA, Benediktsson H, Burdick JF, Cohen AH, Colvin RB, et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int. 1993;44(2):411–22.
Article
CAS
PubMed
Google Scholar
Mengel M, Sis B, Haas M, Colvin RB, Halloran PF, Racusen LC, et al. Banff 2011 Meeting report: new concepts in antibody-mediated rejection. Am J Transplant. 2012;12(3):563–70.
Article
PubMed Central
CAS
PubMed
Google Scholar
Gupta A, Iveson V, Varagunam M, Bodger S, Sinnott P, Thuraisingham RC. Pretransplant donor-specific antibodies in cytotoxic negative crossmatch kidney transplants: are they relevant? Transplantation. 2008;85(8):1200–4.
Article
CAS
PubMed
Google Scholar
Ogura K, Terasaki PI, Johnson C, Mendez R, Rosenthal JT, Ettenger R, et al. The significance of a positive flow cytometry crossmatch test in primary kidney transplantation. Transplantation. 1993;56(2):294–8.
Article
CAS
PubMed
Google Scholar
Karpinski M, Rush D, Jeffery J, Exner M, Regele H, Dancea S, et al. Flow cytometric crossmatching in primary renal transplant recipients with a negative anti-human globulin enhanced cytotoxicity crossmatch. J Am Soc Nephrol. 2001;12(12):2807–14.
CAS
PubMed
Google Scholar
Bryan CF, McDonald SB, Luger AM, Shield CF, Winklhofer FT, Michael Borkon A, et al. Successful renal transplantation despite low levels of donor-specific HLA class I antibody without IVIg or plasmapheresis. Clin Transplant. 2006;20(5):563–70.
Article
PubMed
Google Scholar
van den Berg-Loonen EM, Billen EV, Voorter CE, van Heurn LW, Claas FH, van Hooff JP, et al. Clinical relevance of pretransplant donor-directed antibodies detected by single antigen beads in highly sensitized renal transplant patients. Transplantation. 2008;85(8):1086–90.
Article
PubMed
Google Scholar
Patel AM, Pancoska C, Mulgaonkar S, Weng FL. Renal transplantation in patients with pre-transplant donor-specific antibodies and negative flow cytometry crossmatches. Am J Transplant. 2007;7(10):2371–7.
Article
CAS
PubMed
Google Scholar
Wiebe C, Gibson IW, Blydt-Hansen TD, Karpinski M, Ho J, Storsley LJ, et al. Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant. Am J Transplant. 2012;12(5):1157–67.
Article
CAS
PubMed
Google Scholar
Everly MJ, Rebellato LM, Haisch CE, Ozawa M, Parker K, Briley KP, et al. Incidence and impact of de novo donor-specific alloantibody in primary renal allografts. Transplantation. 2013;95(3):410–7.
Article
CAS
PubMed
Google Scholar
Terasaki PI, Ozawa M. Predicting kidney graft failure by HLA antibodies: a prospective trial. Am J Transplant. 2004;4(3):438–43.
Article
CAS
PubMed
Google Scholar
Hirai T, Furusawa M, Omoto K, Ishida H, Tanabe K. Analysis of predictive and preventive factors for de novo DSA in kidney transplant recipients. Transplantation. 2014;98(4):443–50.
Article
CAS
PubMed
Google Scholar
Archdeacon P, Chan M, Neuland C, Velidedeoglu E, Meyer J, Tracy L, et al. Summary of FDA antibody-mediated rejection workshop. Am J Transplant. 2011;11(5):896–906.
Article
CAS
PubMed
Google Scholar
Elwyn G, Crowe S, Fenton M, Firkins L, Versnel J, Walker S, et al. Identifying and prioritizing uncertainties: patient and clinician engagement in the identification of research questions. J Eval Clin Pract. 2010;16(3):627–31.
PubMed
Google Scholar
Brett J, Staniszewska S, Mockford C, Herron-Marx S, Hughes J, Tysall C, et al. Mapping the impact of patient and public involvement on health and social care research: a systematic review. Health Expect. 2014;17(5):637–50.
Article
PubMed
Google Scholar
Chalmers I, Bracken MB, Djulbegovic B, Garattini S, Grant J, Gulmezoglu AM, et al. How to increase value and reduce waste when research priorities are set. Lancet. 2014;383(9912):156–65.
Article
PubMed
Google Scholar
Chalmers I, Glasziou P. Avoidable waste in the production and reporting of research evidence. Lancet. 2009;374(9683):86–9.
Article
PubMed
Google Scholar
PCORI: Patient-Centered Outcomes Research Institute. http://www.pcori.org/. Accessed January 3, 2015.
INVOLVE: National Institute for Health Research. INVOLVE 2014. http://www.invo.org.uk/. Accessed January 3, 2015.
Jaramillo A, Welch VA, Ueffing E, Gruen RL, Bragge P, Lyddiatt A, et al. Prevention and self-management interventions are top priorities for osteoarthritis systematic reviews. J Clin Epidemiol. 2013;66(5):503–10. e4.
Article
PubMed
Google Scholar
Elberse JE, Pittens CA, de Cock BT, Broerse JE. Patient involvement in a scientific advisory process: setting the research agenda for medical products. Health Policy. 2012;107(2–3):231–42.
Article
PubMed
Google Scholar
The James Lind Alliance. http://www.lindalliance.org/. Accessed January 3, 2015.
Manns B, Hemmelgarn B, Lillie E, Dip SC, Cyr A, Gladish M, et al. Setting research priorities for patients on or nearing dialysis. Clin J Am Soc Nephrol. 2014;9(10):1813–21.
Article
PubMed
Google Scholar
Tong A, Chando S, Crowe S, Manns B, Winkelmayer WC, Hemmelgarn B, et al. Research priority setting in kidney disease: a systematic review. Am J Kidney Dis. 2015;65(5):674–83.
Article
PubMed
Google Scholar
Tong A, Sainsbury P, Carter SM, Hall B, Harris DC, Walker RG, et al. Patients’ priorities for health research: focus group study of patients with chronic kidney disease. Nephrol Dial Transplant. 2008;23(10):3206–14.
Article
PubMed
Google Scholar
Bartosh SM, Ryckman FC, Shaddy R, Michaels MG, Platt JL, Sweet SC. A national conference to determine research priorities in pediatric solid organ transplantation. Pediatr Transplant. 2008;12(2):153–66.
Article
PubMed
Google Scholar
Opelz G, Döhler B. HLA matching and kidney transplantation: beyond graft survival. Clin Transpl. 2013;121–6.
Patrick D, Guyatt GH, Acquadro C. Chapter 17: Patient-reported outcomes. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008. http://www.cochrane-handbook.org.
Denhaerynck K, Dobbels F, Cleemput I, Desmyttere A, Schafer-Keller P, Schaub S, et al. Prevalence, consequences, and determinants of nonadherence in adult renal transplant patients: a literature review. Transpl Int. 2005;18(10):1121–33.
Article
PubMed
Google Scholar
Pinsky BW, Takemoto SK, Lentine KL, Burroughs TE, Schnitzler MA, Salvalaggio PR. Transplant outcomes and economic costs associated with patient noncompliance to immunosuppression. Am J Transplant. 2009;9(11):2597–606.
Article
CAS
PubMed
Google Scholar
Greenstein S, Siegal B. Compliance and noncompliance in patients with a functioning renal transplant: a multicenter study. Transplantation. 1998;66(12):1718–26.
Article
CAS
PubMed
Google Scholar
Tong A, Howell M, Wong G, Webster AC, Howard K, Craig JC. The perspectives of kidney transplant recipients on medicine taking: a systematic review of qualitative studies. Nephrol Dial Transplant. 2011;26(1):344–54.
Article
PubMed
Google Scholar
Gordon EJ, Gallant M, Sehgal AR, Conti D, Siminoff LA. Medication-taking among adult renal transplant recipients: barriers and strategies. Transpl Int. 2009;22(5):534–45.
Article
PubMed Central
PubMed
Google Scholar
Reimer J, Franke GH, Philipp T, Heemann U. Quality of life in kidney recipients: comparison of tacrolimus and cyclosporine-microemulsion. Clin Transplant. 2002;16(1):48–54.
Article
PubMed
Google Scholar
Hathaway D, Winsett R, Prendergast M, Subaiya I. The first report from the patient outcomes registry for transplant effects on life (PORTEL): differences in side-effects and quality of life by organ type, time since transplant and immunosuppressive regimens. Clin Transplant. 2003;17(3):183–94.
Article
PubMed
Google Scholar
De Geest S, Schafer-Keller P, Denhaerynck K, Thannberger N, Kofer S, Bock A, et al. Supporting medication adherence in renal transplantation (SMART): a pilot RCT to improve adherence to immunosuppressive regimens. Clin Transplant. 2006;20(3):359–68.
Article
PubMed
Google Scholar
Chisholm MA, Mulloy LL, Jagadeesan M, DiPiro JT. Impact of clinical pharmacy services on renal transplant patients' compliance with immunosuppressive medications. Clin Transplant. 2001;15(5):330–6.
Article
CAS
PubMed
Google Scholar
Kasbia GS, Farragher J, Kim SJ, Famure O, Jassal SV. A cross-sectional study examining the functional independence of elderly individuals with a functioning kidney transplant. Transplantation. 2014;98(8):864–70.
Article
PubMed
Google Scholar
Humar A, Denny R, Matas AJ, Najarian JS. Graft and quality of life outcomes in older recipients of a kidney transplant. Exp Clin Transplant. 2003;1(2):69–72.
PubMed
Google Scholar
Cornella C, Brustia M, Lazzarich E, Cofano F, Ceruso A, Barbe MC, et al. Quality of life in renal transplant patients over 60 years of age. Transplant Proc. 2008;40(6):1865–6.
Article
CAS
PubMed
Google Scholar
Laupacis A, Keown P, Pus N, Krueger H, Ferguson B, Wong C, et al. A study of the quality of life and cost-utility of renal transplantation. Kidney Int. 1996;50(1):235–42.
Article
CAS
PubMed
Google Scholar
Bachmann S, Finger C, Huss A, Egger M, Stuck AE, Clough-Gorr KM. Inpatient rehabilitation specifically designed for geriatric patients: systematic review and meta-analysis of randomised controlled trials. BMJ. 2010;340:c1718.
Article
PubMed Central
PubMed
Google Scholar
Chang JT, Morton SC, Rubenstein LZ, Mojica WA, Maglione M, Suttorp MJ, et al. Interventions for the prevention of falls in older adults: systematic review and meta-analysis of randomised clinical trials. BMJ. 2004;328(7441):680.
Article
PubMed Central
PubMed
Google Scholar
Gill TM, Baker DI, Gottschalk M, Peduzzi PN, Allore H, Byers A. A program to prevent functional decline in physically frail, elderly persons who live at home. N Engl J Med. 2002;347(14):1068–74.
Article
PubMed
Google Scholar
Cheema BS, Singh MA. Exercise training in patients receiving maintenance hemodialysis: a systematic review of clinical trials. Am J Nephrol. 2005;25(4):352–64.
Article
PubMed
Google Scholar
Forrest GP. Inpatient rehabilitation of patients requiring hemodialysis. Arch Phys Med Rehabil. 2004;85(1):51–3.
Article
PubMed
Google Scholar
Howell MR, Wong G, Tong A, Tan HT, Craig J, Howard K. Quality of life outcomes reported in randomised controlled trials of immunosuppressive drug regimens in kidney transplantation: a systematic review. Transplantation. 2012;94(10S):182.
Article
Google Scholar
Valderas JM, Kotzeva A, Espallargues M, Guyatt G, Ferrans CE, Halyard MY, et al. The impact of measuring patient-reported outcomes in clinical practice: a systematic review of the literature. Qual Life Res. 2008;17(2):179–93.
Article
CAS
PubMed
Google Scholar